Genmab Q3 Revenue Hits $1.19B, Profit Surges to $342M Beating Analyst Forecasts

According to Q3 results, Genmab reported third-quarter revenue of $1.19 billion, slightly missing analyst expectations of $1.2 billion.

Net profit reached $342 million, significantly exceeding analyst estimates of $218.8 million.

Disclaimer: This content is for informational purposes only and does not constitute investment advice or encourage the buying or selling of crypto assets. It is intended to provide information about industry developments and is not directly related to the services offered by Gate TR. Although information obtained from third-party sources has been carefully reviewed, Gate TR assumes no responsibility for any errors or omissions. Crypto assets involve high risks and may experience significant price fluctuations. Before making any investment decisions, you should assess your financial situation and risk tolerance, conduct your own research, and make decisions independently.